Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

11. Avril 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1930


	Articles 1 - 20 / 38593

	Deepath-SCC: a deep learning model for accurate tissue origin identification in squamous cell carcinoma. NPJ Precis Oncol Lu S, Pang Y, Wen H, Hu L, Zhou X, Yang X, Qi X, Liu C, Liu J, Qi P, Huang S, Xu Q, Sun Y, Wang Q. PMID: 41963625 [PubMed - as supplied by publisher]
	Genome wide association analysis and association of genetic risk and lifestyle with upper gastrointestinal cancer among an endoscopy-screened cohort in China. Sci Bull (Beijing) He F, Ran X, Jiang H, Fan Z, Zhang Y, Wang J, Hao C, Song G, Gong Y, Li Y, Li X, Chen R, Zhang H, Constanza Camargo M, Abnet CC, Wang S, Wei W. PMID: 41963194 [PubMed - as supplied by publisher]
	Tislelizumab Combined With Induction Chemotherapy and Concurrent Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter, Randomized, Phase II Trial (EC-CRT-002). J Clin Oncol Chen B, Liu S, Zhu Y, Zhang J, Bao Y, Meng F, Zhang L, Cheng X, Xuzhang W, Chen B, Wang R, Li Z, Hu Y, Liu M, Lv Y, Li J, Dragomir MP, Chen M, Li Q, Yang H, Xi M. PMID: 41962116 [PubMed - as supplied by publisher]
	Endoscopic findings predictive of pathologic upstaging in T2N0 esophageal cancer. JTCVS Open Tsai LL, Bommakanti S, Kapula N, Satoyoshi M, Aboujudom C, Elliott IA, Guenthart BA, Liou DZ, Lui NS, Backhus LM, Shrager JB, Berry MF. PMID: 41960066 [PubMed]
	Prediction of clinically significant complication following neoadjuvant chemoimmunotherapy in resectable esophageal cancer: a dynamic systemic inflammatory biomarker-based model. Front Immunol Chen M, Yang Z, Huang Y, Li H, Zeng T, Zhang S, Huang G, Chen C, Zheng B. PMID: 41958656 [PubMed - indexed for MEDLINE]
	Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib study. J Immunother Cancer Perez-Gracia JL, Mellado B, Hansen AR, Alonso-Gordoa T, Gomez-Roca C, Løvendahl Eefsen R, Negrier S, Suárez C, Lee JL, Hussain A, Pedrazzoli P, Moreno V, Rodriguez-Vida A, Sosman JA, Waddell T, Bedke J, Park SH, Sznol M, Spychaj L, Andersson E, Julien-Laferriere A, Cheng WY, Watson C, Silva AP, Heichinger C, Staedler N, Sleiman N, Dejardin D, Boetsch C, Evers S, Vardar T, Ardeshir-Tandon C, Dorado Pérez J, Charo J, Keshelava N, Kraxner A, Teichgräber V, Powles T. PMID: 41956546 [PubMed - indexed for MEDLINE]
	The clinical impact of precise assessment of predictive biomarkers in gastroesophageal cancer: focus on the PD-L1 combined positive score (CPS) and tumor area positivity (TAP) systems. Pathologica Gambella A, Angerilli V, Grillo F, Pietrantonio F, Vanoli A, Parente P, Cassoni P, Macciomei MC, Caputo A, Carbone FG, Taffon C, Giordano C, Mastracci L, Fassan M. PMID: 41954339 [PubMed - indexed for MEDLINE]
	Long-term prognostic comparison of surgery followed by adjuvant chemoradiotherapy versus definitive chemoradiotherapy in T4N0-3M0 esophageal squamous cell carcinoma: a single-center retrospective cohort study. Front Oncol Wen S, Wang H, Zhao X, Li S, Song C, Deng W, Wen J, Zhu S, Shen W. PMID: 41952693 [PubMed]
	Telerehabilitation for Pain, Function, and Quality of Life in Patients with Cancer: A Systematic Review. Oncol Ther Ordoñez-Mora LT, Urrea-Arango DC, Avila-Valencia JC, Estela-Zape JL, Morales-Osorio MA, Serna-Orozco MF. PMID: 41949753 [PubMed - as supplied by publisher]
	Research Progress of Nanodelivery Platforms in the Diagnosis and Treatment of Esophageal Cancer. Int J Nanomedicine Sun S, Huang H, Hong H, Lu W, Qiu L, Liu S, Huang S, Ye K, Sun J, Lai G, Liu J. PMID: 41948173 [PubMed - indexed for MEDLINE]
	Gastric synovial sarcoma: the critical role of molecular techniques in diagnosis of an ultra-rare cancer. BMJ Case Rep Elango T, Tolstrup J, Penninga L. PMID: 41946534 [PubMed - indexed for MEDLINE]
	Cancer burden and the contributions of risk factors in China: A systematic analysis for the Global Burden of Disease Study 2021. Chin Med J (Engl) Wu Z, Pang S, Mei Y, Qin C, Jin Y, Lin R. PMID: 41945877 [PubMed - indexed for MEDLINE]
	Next step after endoscopic resection for superficial esophageal squamous cell carcinoma: metastatic risk assessment and management of non-curative resection cases. Clin Endosc Ishihara R. PMID: 41943646 [PubMed]
	Biological Characteristics and Therapeutic Strategies for Resectable Locally Advanced Esophagogastric Junction Cancer: A Comprehensive Update. J Gastric Cancer Fujiwara K, Matsuda S, Morimoto Y, Matsui K, Takeuchi M, Kawakubo H, Kitagawa Y. PMID: 41942354 [PubMed - indexed for MEDLINE]
	Impact of immunochemotherapy administration sequence on overall survival in advanced esophageal and gastric cancers: a propensity score-matched multicenter analysis. Cancer Immunol Immunother Hang J, Wu L, Xiao L, Duan Q, Zhao H, Huang J, Guo J, Huang Y, Zhang D, Cheng G, Dong X, Xue P, Chang J. PMID: 41941004 [PubMed - indexed for MEDLINE]
	Exploratory identification of lycorine as a potential inhibitor of the ACP2/YME1L1 prognostic axis in esophageal squamous cell carcinoma: a multi-omics and computational hypothesis. Mol Genet Genomics Chen F, Zhang J, Xu Y, Wang Y, Cheng J. PMID: 41940976 [PubMed - in process]
	Efficacy of surgery versus definitive chemoradiotherapy following neoadjuvant chemotherapy in T4 esophageal squamous cell carcinoma: a retrospective cohort analysis. Front Oncol Wen S, Wang H, Zhao X, Wen J, Liu X, Yan K, Li S, Song C, Shen W. PMID: 41939449 [PubMed]
	Socioeconomic disparities in treatment and survival of oesophageal and gastric cancer in the Netherlands: a nationwide population-based study. Lancet Reg Health Eur van der Aa DC, Teeken MD, van Laarhoven HWM, Gisbertz SS, Lagarde SM, Mohammad NH, van Rossum PSN, Verhoeven RHA, van Berge Henegouwen MI. PMID: 41939011 [PubMed]
	Megestrol acetate versus dexamethasone to prevent nausea and vomiting in patients with gastric or gastro-oesophageal junction cancer treated with oxaliplatin-based chemotherapy: study protocol of a multicentre, randomised, non-inferiority trial. BMJ Open Luo H, Hu Q, Zeng L, Huang Q, Luo Y, Li T, Chen P, Yi C, Gou H. PMID: 41932699 [PubMed - indexed for MEDLINE]
	Microbiota and esophageal cancer: From dysbiosis to carcinogenesis. Crit Rev Oncol Hematol Rajabnia A, Kazeminejad E, Firouzjaei DA, Javadi K. PMID: 41932533 [PubMed - as supplied by publisher]

Articles 1 - 20 / 38593

Page 1 de 1930



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité